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Background-—Atrial ﬁbrillation (AF) results in signiﬁcant morbidity and mortality. Genome-wide association studies (GWAS) have
identiﬁed genetic variants associated with AF. Whether genetic variants associated with AF are also associated with atrial
structure, an intermediate phenotype for AF, has had limited investigation. We sought to investigate associations between single
nucleotide polymorphisms (SNPs) and atrial structure obtained by cardiovascular imaging in the Framingham Heart Study.
Methods and Results-—We selected 11 SNPs that have been associated with AF in GWAS. We examined the SNPs’ relations to
cross-sectional left atrial (LA) dimensions (determined by transthoracic echocardiography) and LA volume (determined by
cardiovascular magnetic resonance [CMR]) employing linear regression. The total sample included 1555 participants with CMR LA
volume (age 609 years, 53% women) and 6861 participants with echocardiographic LA diameter (age 4813 years, 52% women)
measured. We employed a signiﬁcance threshold of P<0.0023 to account for multiple testing of the 11 SNPs and 2 LA measures. In
a primary analysis, no SNPs were signiﬁcantly related to the LA measures. Likewise, in secondary analyses excluding individuals
with prevalent AF (n=77, CMR sample; n=105, echocardiography sample) no SNPs were related to LA volume or diameter.
Conclusion-—In a community-based cohort, we did not identify a statistically signiﬁcant association between selected SNPs
associated with AF and measures of LA anatomy. Further investigations with larger longitudinally assessed samples and a broader
array of SNPs may be necessary to determine the relation between genetic loci associated with AF and atrial structure. (JA m
Heart Assoc. 2014;3:e000616 doi: 10.1161/JAHA.113.000616)
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A
trial ﬁbrillation (AF) is increasing in prevalence and is
associated with signiﬁcant morbidity and mortality.
1
Large genome-wide association studies (GWAS) have identi-
ﬁed novel genetic loci related to AF and PR interval. To date,
11 AF-associated, single nucleotide polymorphisms (SNPs)
have been identiﬁed and replicated.
2–7 Furthermore, left atrial
size has been related to the occurrence of incident AF and
recurrence following radiofrequency catheter ablation.
8,9
Whether SNPs associated with AF are related to LA size or
dimensions has had limited investigation. We therefore
hypothesized that SNPs related to AF would be associated
with measures of atrial structure, an AF intermediate pheno-
type. We speciﬁcally examined the relations between each
SNP and left atrial (LA) dimension, as determined by
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ORIGINAL RESEARCHtransthoracic echocardiography, and LA volume, as deter-
mined by cardiovascular magnetic resonance (CMR). Demon-
strating such an association would suggest that genetic




The Framingham Heart Study is a prospective, community-
based investigation of the epidemiology of cardiovascular
disease. In brief, the Study began in 1948 by enrolling the
Original Cohort, followed by the children of the Original
Cohort and their spouses in 1971, known as the Offspring
Cohort.
10 In turn, children of the Offspring Cohort were
enrolled in 2002 as the Third Generation Cohort.
11 Partici-
pants have undergone routine examinations every 2 to
8 years since enrollment including extensive phenotyping
with periodic noninvasive cardiovascular imaging studies and
comprehensive genotyping. The present analysis included
participants who attended Offspring Cohort examination 6
(n=3532), examination 7 (n=3539), and the Third Genera-
tion’s ﬁrst examination (n=4095). The study was approved
by the Boston University Medical Center Institutional
Review Board, and all participants provided written informed
consent.
Echocardiography
Participants in Offspring examination 6 (1995–1998) and
Third Generation examination 1 (2002–2005) underwent
transthoracic echocardiography employing a standardized
protocol. Echocardiography in the Framingham Heart Study
has been well described and was performed using a Hewlett-
Packard Sonos 1000 in the Offspring Cohort and
Hewlett-Packard Sonos 5500 in the Third Generation Cohort
(Hewlett-Packard Medical Products) by certiﬁed sonographers
and over-read by technicians and cardiologists.
12,13 LA
diameter measurement was conducted according to guide-
lines from the American Society of Echocardiography
14 and
entailed M-mode measurement recorded at end-systole in the
parasternal long- or short-axis views. The maximum distance
from the wall of the posterior aortic root to the posterior LA
was measured in up to 4 cycles for each participant. Prior
analyses have described excellent inter- and intra-rater
reproducibility for Framingham Heart Study LA diameter
measurement using this approach.
15 In total, 6861 Framing-
ham Heart Study participants underwent echocardiography at
the examinations relevant to this analysis. Left ventricular
mass and fractional shortening also were calculated as
described previously.
12 All echocardiography reading was
done ofﬂine by readers who were blinded to participant
clinical characteristics.
Cardiovascular Magnetic Resonance
A subset of participants in the Offspring examination 7
(1998–2001) was included in a study using noncontrast
CMR. Exclusions for CMR included any identiﬁed contrain-
dication to CMR (eg, deﬁbrillator or pacemaker implantation)
or severe claustrophobia. Participants underwent imaging in
the supine position in a 1.5 Tesla MRI scanner (Gyroscan
NT; Philips Healthcare). After scout images to determine the
position and orientation of the heart within the thorax
an electrocardiogram-gated, steady-state free precession
cine sequence was acquired in the anatomic 2-chamber and
4-chamber orientations. Imaging measures included
TR=3.2 ms, TE=1.6 ms, ﬂip angle=60°, slice thick-
ness=10 mm with 1.991.6-mm
2 in-plane spatial resolution.
Images were processed off-line using commercially available
software (MASS v.6.1; QT-Medis) by a single observer (GA).
In each view, the systolic frame immediately prior to mitral
valve opening was identiﬁed and the cross-sectional area of
the LA was manually planimetered. Particular care was
taken to exclude left atrial appendage and pulmonary vein
ostia from left atrial area. Left atrial volume was then
calculated using the biplane formula: =89A2c9A4c/(3pLmin)
for which A2c and A4c are the planimetered areas and Lmin is
the minimum of the 2-chamber and 4-chamber LA lengths.
In total, 1810 participants from the Offspring Cohort
underwent CMR using a standardized protocol.
16 All read-
ers were blinded to participant identity and clinical charac-
teristics.
Genotyping and SNP Selection
Genotyping of Framingham Heart Study participants has been
described elsewhere.
17 In the present study, SNPs were
selected from their established association with AF in large
GWAS including Framingham Heart Study Offspring and
Original Cohort participants.
2–7 Only SNPs that had reached
statistical signiﬁcance in GWAS meta-analyses after applica-
tion of Bonferroni correction (P<5.0910
8) were included in
the present analysis.
Covariates
Covariates were selected for their established associations
with AF in the Framingham Heart Study and other cohorts,
and for their potential relation to longitudinal modiﬁcation of
atrial structure.
13,18,19 Covariates selected for inclusion were
age, sex, body mass index, systolic blood pressure, treatment
for hypertension, valvular heart disease, and prevalent
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Hcardiovascular disease and heart failure. Participants with
prevalent AF, ie, a history of documented AF according to
Framingham Heart Study criteria that were present at or prior
to the imaging assessment, were included in our primary
analysis. The Framingham Heart Study protocol for adjudicat-
ing AF has been described elsewhere.
19
Statistical Analyses
We examined the distributions of continuous variables (means,
standard deviations, summaries). We examined correlations
between clinical characteristics and cardiac imaging measures
using the Pearson product-moment correlation coefﬁcient. For
CMR analysis we employed linear mixed models to determine
the associations between selected SNPs and measures of LA
volume with a random effect to account for sibling correlation.
Forechoanalysisconsideringthatthesamplewascomposedof
2 generations, we used generalized estimating equations to
obtain robust standard errors in evaluating the association
betweenSNPsandLAdimension.Allcorrelationandregression
models wereadjusted forageandsex.Weconductedaprimary
analysis including participants with prevalent AF, and a
secondary analysis that excluded participants with prevalent
AF. We conducted a post hoc power calculation using the
method described by Cohen.
20 All analyses were performed
using SAS version 9.2 (SAS Institute). A P value <0.0023 (0.05
with 11 SNPs and 2 LA phenotypes) was deemed statistically
signiﬁcant to account for multiple testing.
Results
The study sample for the examination of selected SNPs and
LA measures consisted of 6861 participants with echocar-
diographic LA dimension and 1555 participants with CMR LA
volume. The LA imaging measures were considered as
separate assessments in relation to the selected AF SNPs.
In total 1465 participants had both CMR and echocardiogra-
phy, 90 CMR only, and 5396 echocardiography only. We
analyzed them separately because they were done at different
time points and with different technology.
The characteristics of the study samples and the distribu-
tion of LA measures are described in Table 1. The sample with
echocardiographic LA dimension was larger and younger than
the CMR LA volume sample, reﬂecting the contribution of the
younger Third Generation Cohort and earlier examination of
the Offspring Cohort. Mean left ventricular mass differed
between echocardiographic and CMR assessments. The mean
LA volume by CMR was 73.523.8 mL. Echocardiographic LA
volume was not determined. The number of participants with
prevalent AF was limited (5.0% of the CMR cohort and 1.5% of
the echocardiography cohort).
Table 2 describes correlations between the clinical char-
acteristics and the imaging measures. The correlation
between LA volume and LA diameter was moderate (r=0.41,
P<0.001). We observed a signiﬁcant correlation (r=0.33,
P<0.001) between LA volume and left ventricular mass as
measured by CMR. We also found signiﬁcant, modest
associations between both LA volume and LA dimension with
prevalent AF.
The associations between the relevant SNPs and the LA
measures are shown in Table 3. Two SNPs were associated
with CMR LA volume as determined by CMR. Both SNPs were
in proximity to the PITX2 gene, which regulates cardiac
development and atrial electrical function.
21 When we
adjusted for body surface area, the associations between
these 2 SNPs and LA volume were no longer signiﬁcant.
In secondary analyses we excluded participants with
prevalent AF (n=77 in the CMR sample and n=105 in the
echocardiography sample). Results of the secondary analysis
arereportedinTable 4.Thestatisticalassociationbetween2of
the PITX2 SNPs and LA volume as measured by CMR
were nominally signiﬁcant, but none of the ﬁndings met
our threshold for statistical signiﬁcance. A single SNP
(rs2200733) in proximity to PITX2 was associated
(b=1.220.60,P=0.04)withLAvolumefollowingadjustment
for body surface area. A second SNP (rs2106261) in proximity
to the ZFHX3 gene was related (b=0.220.11, P=0.04) to LA
diameter. We were further concerned about potential misclas-
siﬁcation of atrial structure by including individuals with
valvular heart disease. Therefore, we conducted an analysis
excludingthe2%ofindividualswithvalvularheartdisease;the
results were not substantively affected (Table 5).
In view of our negative ﬁndings, we conducted a post-hoc
power calculation. Among the 11 SNPs, rs2200733 had the
smallest P value in association with LA volume (P=0.02),
explaining 0.23% of residual variability in LA volume. Given the
limited-sized sample (n=1555), we had only 14% statistical
power to detect such an effect size at alpha=0.0023 level.
With this sample size, we would have 40% and 60% power to
detect a SNP explaining 0.50% and 0.69% variability in LA
volume, respectively. Rs2106261 had the smallest P value in
association with LA diameter as determined by echocardiog-
raphy (P=0.06), explaining 0.10% of the residual variability in
LA diameter. Given the sample size (n=6861), we had 38%
power to detect such an effect size at alpha=0.0023 level. We
would have 50% and 70% power to detect a SNP explaining
0.14% and 0.19% variability in LA dimension, respectively.
Discussion
We hypothesized that selected SNPs, identiﬁed from large
GWAS for AF, are associated with measures of atrial structure
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Hdetermined by noninvasive cardiac imaging in a community-
based cohort. Our hypothesis was informed by animal and
human electrophysiologic studies and further consideration
of genetic contributions to atrial electrical and structural
remodeling. As atrial structure serves as an intermediate
phenotype for AF and is directly related to risk,
8,22 we
postulate that AF genetic variants mediated atrial structural
remodeling. However, our analysis did not identify a signiﬁcant
association between the genetic loci and atrial structures.
The AF SNPs examined in our analysis were selected from
GWAS. Speciﬁcally, 3 of the SNPs studied here (rs2200733,
rs17570669, and rs3853445) are on chromosome 4q25 and
are located upstream of the PITX2 gene, which is relevant for
atrial tissue development. PITX2c-deﬁcient mice do not
develop pulmonary myocardial cells or pulmonary myocardial
sleeves.
23 The PITX2c isoform impedes LA sinus node
development.
24 PITX2c / increases vulnerability to atrial
arrhythmias.
25 In studies of human atrial tissue, PITX2
expression levels are 2 orders of magnitude higher in the
LA compared to the right atrium or the ventricles.
26 Finally,
PITX2c heterozygote mice were susceptible to AF induced by
pacing and had shorter atrial action potential durations
Table 1. Clinical Characteristics of the Framingham Heart Study Samples According to Cardiac Imaging Modality
CMR (n=1555) Echocardiography (n=6861)
Clinical characteristics
Age, y 6094 8 13
Women, % 827 (53) 3626 (52)
Body mass index, kg/m
2 27.84.8 27.35.3
Body surface area, m
2 1.900.23 1.910.25
Systolic blood pressure, mm Hg 12518 12217
Hypertension treatment, % 450 (29) 1144 (17)
Prevalent cardiovascular disease, % 93 (6.0) 186 (2.7)
Prevalent atrial fibrillation, % 77 (5.0) 104 (1.5)
Valvular heart disease, % 31 (2.0) 124 (1.8)
Imaging
LV ejection fraction, % 677 —
LV mass, g 10630 15943
LA volume, mL 73.523.8 —
LA dimension, mm — 38.25.3
LV fractional shortening — 0.360.05
Continuous measures provided as meansSD and categorical as N (%). CMR indicates cardiovascular magnetic resonance; LA, left atrium; LV, left ventricular.
Table 2. Age- and Sex-Adjusted Correlations (r) Between Selected Clinical and Imaging Variables in the Framingham Heart Study
Cardiovascular Magnetic
Resonance LA Volume (mL)
Echocardiography LA
Dimension (mm)
Body mass index, kg/m
2 0.17* 0.45*
Systolic blood pressure, mm Hg 0.08
† 0.14*
Hypertension treatment 0.13* 0.18*
Prevalent cardiovascular disease 0.13* 0.10*
Prevalent atrial fibrillation 0.21* 0.14*
LV ejection fraction, %
‡ 0.03 0.03
LV mass, g 0.33* 0.60*
LA diameter, mm 0.41* —
LA indicates left atrium; LV, left ventricular.
*P<0.001.
†P<0.05.
‡Refers to fractional shortening for echocardiography assessment.
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Hcompared with the wild type controls.
27 Our study did not
identify an association between the 4q25 SNPs and measures
of atrial structure. Further studies of the AF-associated SNPs,
PITX2 and expression are essential to determine their
relevance towards atrial structure and function.
Many of the other AF-risk SNPs do not have a clear relation
to cardiac development or atrial structure. SNP rs13376333
is intronic to KCNN3, a gene that encodes a calcium-activated
potassium channel.
4 SNP rs2106261 is found in a zinc
ﬁnger homeobox transcription factor, ZFHX3, which partici-
pates in myogenic and neuronal differentiation. The associ-
ation of this SNP with AF has been replicated in an Asian
cohort and associated with coronary disease in an African
American cohort.
27,28 SNP rs3807989 is intronic to CAV1,
and has been associated with AF and the PR and QRS
intervals.
17,29,30
Table 3. Age- and Sex-Adjusted Associations Between AF SNPs and LA Measures
SNP Cardiovascular Magnetic Resonance Echocardiography
Chr Coded Allele* Closest Gene
LA Volume (mL) LA Volume, Indexed to BSA LA Dimension (mm)
EstimateSE P Value EstimateSE P Value EstimateSE P Value
rs2200733 4 T PITX2 2.521.19 0.04 0.860.60 0.15 0.100.12 0.41
rs17570669 4 T PITX2 4.491.88 0.02 1.590.94 0.09 0.090.18 0.59
rs3853445 4 C PITX2 1.120.90 0.18 0.510.45 0.26 0.060.09 0.51
rs13376333 1 T KCNN3 0.951.02 0.35 0.450.51 0.38 0.050.10 0.62
rs2106261 16 T ZFHX3 0.411.14 0.72 0.510.57 0.37 0.210.11 0.06
rs6666258 1 C KCNN3 0.951.02 0.35 0.450.52 0.38 0.050.10 0.62
rs3807989 7 A CAV1 0.290.84 0.73 0.330.42 0.42 0.080.08 0.35
rs10821415 9 A C9orf3 0.580.82 0.48 0.220.41 0.56 0.100.11 0.38
rs10824026 10 G SYNPO2L 0.001.09 0.99 0.060.55 0.91 0.0020.08 0.98
rs1152591 14 A SYNE2 0.680.82 0.41 0.490.42 0.24 0.050.09 0.57
rs7164883 15 G HCN4 0.521.07 0.63 0.140.54 0.80 0.120.11 0.28
All analyses age- and sex-adjusted, and echocardiography results further adjusted for cohort. AF indicates atrial ﬁbrillation; BSA, body surface area; Chr, chromosome; LA, left atrium; SNP,
single nucleotide polymorphism.
*All coded alleles are minor alleles and refer to the allele associated with AF risk as identiﬁed in genome-wide association studies referenced in text.
Table 4. Age- and Sex-Adjusted Associations Between AF SNPs and LA Measures, Excluding Prevalent AF
SNP Cardiovascular Magnetic Resonance Echocardiography
Chr Coded Allele* Closest Gene
LA Volume (mL) LA Volume, Indexed to BSA LA Dimension (mm)
EstimateSE P Value EstimateSE P Value EstimateSE P Value
rs2200733 4 T PITX2 3.151.18 0.01 1.220.60 0.05 0.030.11 0.80
rs17570669 4 T PITX2 4.631.81 0.01 1.740.92 0.06 0.050.18 0.78
rs3853445 4 C PITX2 1.130.89 0.20 0.470.45 0.30 0.030.09 0.75
rs13376333 1 T KCNN3 0.581.00 0.56 0.310.51 0.55 0.040.09 0.66
rs2106261 16 T ZFHX3 0.911.12 0.42 0.770.57 0.18 0.220.11 0.04
rs6666258 1 C KCNN3 0.581.00 0.56 0.310.51 0.55 0.040.09 0.66
rs3807989 7 A CAV1 0.040.83 0.96 0.150.42 0.73 0.010.08 0.91
rs10821415 9 A C9orf3 1.030.81 0.21 0.360.41 0.38 0.040.09 0.66
rs10824026 10 G SYNPO2L 1.471.07 0.17 0.720.55 0.19 0.080.11 0.48
rs1152591 14 A SYNE2 0.610.81 0.45 0.310.41 0.46 0.060.08 0.44
rs7164883 15 G HCN4 1.181.05 0.27 0.500.54 0.35 0.020.11 0.87
All analyses age- and sex-adjusted, and echocardiography results further adjusted for cohort. AF indicates atrial ﬁbrillation; BSA, body surface area; Chr, chromosome; LA, left atrium; SNP,
single nucleotide polymorphism.
*All coded alleles are minor alleles and refer to the allele associated with AF risk as identiﬁed in genome-wide association studies referenced in text.
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HWe considered that individuals with genetic polymorphisms
making them susceptible to AF may experience altered LA
structure.
8 However, all the 11 AF SNPs we examined were
not signiﬁcantly associated with LA volume and dimension in
our samples. Further work with a larger sample and longitu-
dinal measures of LA structure may discern if there is a
genetic contribution towards atrial structure and remodeling.
We are not aware of other literature examining SNPs
related to AF and measures of LA structure. A large
(n=12 612) GWAS investigating genetic variants associated
with echocardiographic traits did not identify genetic loci
associated with LA size.
31 Comparison between these 2
studies is difﬁcult as the prior echocardiographic study
examined 2.5 million SNPs in relation to LA diameter in meta-
analysis involving 5 cohorts. In the Framingham Heart Study,
there may be further misclassiﬁcation of LA size by conduct-
ing echocardiographic measurements in the anteroposterior
diameter. M-mode LA measurement has a poor correlation
with LA volume determined by echocardiography.
32
Atrial structural characteristics are likely modiﬁed by
multiple clinical factors, eg, hypertension, left ventricular
diastolic properties, and unrecognized AF. Our analysis did
not include left ventricular diastolic function or other structural
abnormalities that could inﬂuence LA diameter or volume. Our
study is not able to examine the association of the AF SNPs
and functional assessments such as the left atrial functional
index or conduction as measured by P wave indices.
Our study has several important strengths. The Framingham
Heart Study echocardiographic LA dimension and the CMR LA
volume measurements were reproducible and conducted using
standardized techniques. The SNPs selected for inclusion were
identiﬁedfromaseriesoflargeGWAS.However,wenotethatour
studyhasmultiplelimitations.First,theFraminghamHeartStudy
isprimarily ofEuropean descent,limitingour ability to comment
on the generalizability of our results to more diverse cohorts.
Second, we used strict criteria in the selection of the AF-related
SNPsforassociationwithLAdimensions.Itispossiblethatother
genetic loci associated with AF below stringent genome-wide
signiﬁcance thresholds may be related to atrial structure. Third,
we performed the assessments ofLA size at a single time-point.
The AF associated SNPs may have a relation to longitudinal
changes in LA structure that our analysis was not designed to
assess. Consequently, we are not able to comment on the
relationoftheSNPstolongitudinalchangethatwoulddistinguish
atrial remodeling. Whether and how SNPs related to AF are
related to trajectories or changes in LA dimensions remains an
important question.Fourth, ourechocardiographystudiesrelied
on M-mode for determining LA dimension, potentially introduc-
ing systematic misclassiﬁcation of the echocardiography
measures. Fifth, 43% of participants included in the echocardi-
ography cohort also participated in the AF GWAS. While the
overlapinparticipantsmayhavebiasedourresults,Framingham
participants were included as part of large consortia for
determining the GWAS related to AF. Finally, our power
calculation indicates that our sample size had limited statistical
power.Ourstudywouldbeenhancedbyafarlargersamplesize.
In summary, our primary analysis did not identify a relation
between SNPs associated with AF and LA structure in a
community-based study employing echocardiography and
CMR for LA structural characterization. A secondary analysis
Table 5. Age- and Sex-Adjusted Associations Between AF SNPs and LA Measures, Excluding Prevalent AF and VHD
SNP Cardiovascular Magnetic Resonance Echocardiography
Chr Coded Allele* Closest Gene
LA Volume (mL) LA Volume, Indexed to BSA LA Dimension (mm)
EstimateSE P Value EstimateSE P Value EstimateSE P Value
rs2200733 4 T PITX2 2.811.16 0.02 1.080.60 0.07 0.030.11 0.78
rs17570669 4 T PITX2 4.641.79 0.01 1.860.92 0.04 0.010.18 0.96
rs3853445 4 C PITX2 1.150.88 0.19 0.550.45 0.22 0.010.09 0.92
rs13376333 1 T KCNN3 0.870.99 0.38 0.430.51 0.40 0.020.10 0.80
rs2106261 16 T ZFHX3 1.561.10 0.16 0.1.050.56 0.06 0.250.11 0.02
rs6666258 1 C KCNN3 0.870.99 0.38 0.430.51 0.40 0.020.10 0.80
rs3807989 7 A CAV1 0.380.81 0.65 0.320.42 0.44 0.040.08 0.64
rs10821415 9 A C9orf3 1.010.80 0.65 0.380.41 0.36 0.050.09 0.54
rs10824026 10 G SYNPO2L 0.911.05 0.39 0.530.54 0.33 0.080.11 0.45
rs1152591 14 A SYNE2 0.720.80 0.37 0.380.41 0.36 0.090.08 0.27
rs7164883 15 G HCN4 1.271.04 0.22 0.580.54 0.28 0.050.11 0.64
All analyses age- and sex-adjusted, and echocardiography results further adjusted for cohort. AF indicates atrial ﬁbrillation; BSA, body surface area; Chr, chromosome; LA, left atrium;
SNP, single nucleotide polymorphism; VHD, valvular heart disease.
*All coded alleles are minor alleles and refer to the allele associated with AF risk as identiﬁed in genome-wide association studies referenced in text.
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Hexcluding individuals with prevalent AF identiﬁed marginal
associations. Further efforts in larger cohorts are indicated;
demonstrating the relation between genetic exposures and
changes in atrial structure and function may identify key
intermediate steps in the pathogenesis of AF. Future studies
that examine additional genetic loci, genomic expression,
more diverse cohorts, and the association with longitudinal
changes in atrial structure and function may more completely
characterize atrial remodeling and its pathophysiologic
relations with AF.
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